Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:072020)

South Korea flag South Korea · Delayed Price · Currency is KRW
9,040.00
-190.00 (-2.06%)
At close: Mar 9, 2026
-8.22%
Market Cap 85.51B
Revenue (ttm) 39.19B
Net Income (ttm) 3.65B
Shares Out 9.46M
EPS (ttm) 375.11
PE Ratio 24.10
Forward PE n/a
Dividend 200.00 (2.17%)
Ex-Dividend Date Dec 29, 2025
Volume 30,418
Average Volume 45,452
Open 9,230.00
Previous Close 9,230.00
Day's Range 8,950.00 - 9,230.00
52-Week Range 8,780.00 - 10,500.00
Beta 0.51
RSI 35.94
Earnings Date Mar 20, 2026

About KOSDAQ:072020

Choong Ang Vaccine Laboratory Co., Ltd. engages in the research, development, manufacturing, and sale of animal vaccines in South Korea, Asia, Africa, and the United States. It offers swine, poultry, cattle, canine, feline, wild boar, and raccoon vaccines under the SuiShot, PoulShot, BoviShot, CaniShot, and FeliShot brands. The company was founded in 1968 and is headquartered in Daejeon, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1968
Employees 167
Stock Exchange KOSDAQ
Ticker Symbol 072020
Full Company Profile

Financial Performance

In 2022, KOSDAQ:072020's revenue was 39.30 billion, a decrease of -3.95% compared to the previous year's 40.91 billion. Earnings were 4.04 billion, a decrease of -46.80%.

Financial Statements

News

There is no news available yet.